Pneumoconiosis cost-effectiveness of therapy

Jump to navigation Jump to search

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis cost-effectiveness of therapy

CDC on Pneumoconiosis cost-effectiveness of therapy

Pneumoconiosis cost-effectiveness of therapy in the news

Blogs on Pneumoconiosis cost-effectiveness of therapy

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

The most cost-effective method to prevent pneumoconiosis is avoidance of exposure through primary and secondary prevention.

Cost-effectiveness of Therapy

This includes education, behavioral changes, strict regulations and adherence at workplaces, smoking cessation and vaccination against influenza and pneumococcus.

References

Template:WH Template:WS